This was synthesized following a modified literature procedure.
28 (link) Ph
2P(2-quinazoline) (123 mg, 0.4 mmol) and [Cu(MeCN)
4]PF
6 (97 mg, 0.26 mmol) were added to 1 dram vial. MeCN (1 ml) was added and the resulting yellow solution was stirred at r.t. (21 h), during which some product may form and give a yellow suspension. Further Et
2O may be added to precipitate more product. The precipitated solids were isolated
via filtration and washed with Et
2O (5 ml) to give the crude product as a yellow powder that fluorescence orange (8.1 mg, 5.8 μmol, 11% yield). It may be further purified by redissolving it in minimal MeCN and precipitating with Et
2O twice.
δH (400 MHz, CDCl
3, ppm) 9.94 (br s), 8.29 (br s), 8.09 (t,
J = 7.7 Hz), 7.94 (br s), 7.87 (t,
J = 7.1 Hz), 7.16 (br s), 7.09 (br s).
δP{H} (162 MHz, CDCl
3, ppm): 10.68 (br s), −144.03 (sept, PF
6−).
δC (101 MHz, CDCl
3, ppm) 161.44, 149.10, 137.14, 133.14, 131.02, 130.80, 128.89, 128.22.
HRMS(ESI+): [C
2H
3CuN]
+m/
z = 103.9554, calcd = 103.9562. [C
60H
45CuN
6P
3]
+m/
z = 1005.2242, calcd = 1005.2215. [C
40H
30CuN
4P
2]
+m/
z = 691.1262, calcd = 691.1242. [C
22H
18CuN
3P]
+m/
z = 418.0545, calcd = 418.0534. [C
20H
15CuN
2P]
+m/
z = 377.0271, calcd = 377.0269.